Annual SGA
$158.31 M
+$42.32 M+36.48%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual SGA is $158.31 million, with the most recent change of +$42.32 million (+36.48%) on December 31, 2023.
- During the last 3 years, IRWD annual SGA has risen by +$18.31 million (+13.08%).
- IRWD annual SGA is now -31.52% below its all-time high of $231.18 million, reached on December 31, 2017.
Performance
IRWD SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$36.11 M
-$851.00 K-2.30%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly SGA is $36.11 million, with the most recent change of -$851.00 thousand (-2.30%) on September 30, 2024.
- Over the past year, IRWD quarterly SGA has stayed the same.
- IRWD quarterly SGA is now -41.54% below its all-time high of $61.77 million, reached on September 30, 2017.
Performance
IRWD Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$6.81 B
-$2.46 M-0.04%
September 30, 2024
Summary
- As of February 20, 2025, IRWD TTM SGA is -$6.81 billion, with the most recent change of -$2.46 million (-0.04%) on September 30, 2024.
- Over the past year, IRWD TTM SGA has dropped by -$6.95 billion (-4656.46%).
- IRWD TTM SGA is now -2696.12% below its all-time high of -$243.37 million.
Performance
IRWD TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
IRWD Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.5% | 0.0% | -4656.5% |
| 3 y3 years | +13.1% | +25.9% | -6223.3% |
| 5 y5 years | -27.9% | +25.9% | -6223.3% |
IRWD Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.5% | -31.2% | +27.2% | -135.6% | +0.1% |
| 5 y | 5-year | -8.2% | +42.5% | -31.2% | +33.5% | -135.6% | +0.1% |
| alltime | all time | -31.5% | +1361.4% | -41.5% | +630.9% | -2696.1% | +0.1% |
Ironwood Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $36.11 M(-2.3%) | $149.35 M(+0.0%) |
| Jun 2024 | - | $36.96 M(-1.7%) | $149.28 M(-9.4%) |
| Mar 2024 | - | $37.60 M(-2.7%) | $164.80 M(+4.1%) |
| Dec 2023 | $158.31 M(+36.5%) | $38.67 M(+7.3%) | $158.31 M(+6.9%) |
| Sep 2023 | - | $36.05 M(-31.3%) | $148.04 M(+5.3%) |
| Jun 2023 | - | $52.48 M(+68.7%) | $140.61 M(+18.9%) |
| Mar 2023 | - | $31.12 M(+9.6%) | $118.25 M(+1.9%) |
| Dec 2022 | $115.99 M(+4.4%) | $28.39 M(-0.8%) | $115.99 M(-0.3%) |
| Sep 2022 | - | $28.62 M(-5.0%) | $116.29 M(+0.8%) |
| Jun 2022 | - | $30.12 M(+4.4%) | $115.41 M(+2.7%) |
| Mar 2022 | - | $28.86 M(+0.6%) | $112.34 M(+1.1%) |
| Dec 2021 | $111.13 M(-20.6%) | $28.69 M(+3.4%) | $111.13 M(-4.5%) |
| Sep 2021 | - | $27.74 M(+2.6%) | $116.43 M(-5.8%) |
| Jun 2021 | - | $27.05 M(-2.2%) | $123.61 M(-5.8%) |
| Mar 2021 | - | $27.65 M(-18.6%) | $131.21 M(-6.3%) |
| Dec 2020 | $140.00 M(-18.8%) | $33.98 M(-2.7%) | $140.00 M(-3.6%) |
| Sep 2020 | - | $34.93 M(+0.8%) | $145.21 M(-4.0%) |
| Jun 2020 | - | $34.64 M(-5.0%) | $151.20 M(-5.4%) |
| Mar 2020 | - | $36.45 M(-7.0%) | $159.81 M(-7.3%) |
| Dec 2019 | $172.45 M(-21.5%) | $39.19 M(-4.2%) | $172.45 M(-6.1%) |
| Sep 2019 | - | $40.92 M(-5.4%) | $183.68 M(-5.0%) |
| Jun 2019 | - | $43.25 M(-11.9%) | $193.30 M(-7.9%) |
| Mar 2019 | - | $49.09 M(-2.6%) | $209.83 M(-4.7%) |
| Dec 2018 | $219.68 M(-5.0%) | $50.42 M(-0.2%) | $220.23 M(-2.5%) |
| Sep 2018 | - | $50.54 M(-15.5%) | $225.82 M(-4.7%) |
| Jun 2018 | - | $59.77 M(+0.5%) | $237.06 M(+0.8%) |
| Mar 2018 | - | $59.50 M(+6.2%) | $235.08 M(+1.7%) |
| Dec 2017 | $231.18 M(+33.4%) | $56.01 M(-9.3%) | $231.18 M(+0.3%) |
| Sep 2017 | - | $61.77 M(+6.9%) | $230.38 M(+7.9%) |
| Jun 2017 | - | $57.79 M(+3.9%) | $213.59 M(+10.8%) |
| Mar 2017 | - | $55.60 M(+0.7%) | $192.72 M(+11.2%) |
| Dec 2016 | $173.28 M | $55.21 M(+22.7%) | $173.28 M(+15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $44.99 M(+21.9%) | $149.58 M(+10.8%) |
| Jun 2016 | - | $36.92 M(+2.1%) | $135.03 M(+3.0%) |
| Mar 2016 | - | $36.17 M(+14.8%) | $131.07 M(+4.6%) |
| Dec 2015 | $125.25 M(+5.8%) | $31.51 M(+3.5%) | $125.25 M(+0.7%) |
| Sep 2015 | - | $30.44 M(-7.6%) | $124.31 M(+1.6%) |
| Jun 2015 | - | $32.95 M(+8.6%) | $122.41 M(+3.1%) |
| Mar 2015 | - | $30.35 M(-0.7%) | $118.75 M(+0.4%) |
| Dec 2014 | $118.33 M(-4.0%) | $30.57 M(+7.1%) | $118.33 M(+1.6%) |
| Sep 2014 | - | $28.54 M(-2.6%) | $116.48 M(-1.5%) |
| Jun 2014 | - | $29.30 M(-2.1%) | $118.21 M(-1.3%) |
| Mar 2014 | - | $29.92 M(+4.2%) | $119.78 M(-2.8%) |
| Dec 2013 | $123.23 M(+33.2%) | $28.72 M(-5.1%) | $123.23 M(-3.6%) |
| Sep 2013 | - | $30.26 M(-2.0%) | $127.78 M(+6.2%) |
| Jun 2013 | - | $30.87 M(-7.5%) | $120.36 M(+9.8%) |
| Mar 2013 | - | $33.37 M(+0.3%) | $109.59 M(+18.4%) |
| Dec 2012 | $92.54 M(+101.5%) | $33.27 M(+45.6%) | $92.54 M(+24.7%) |
| Sep 2012 | - | $22.85 M(+13.7%) | $74.23 M(+19.1%) |
| Jun 2012 | - | $20.10 M(+23.2%) | $62.31 M(+17.5%) |
| Mar 2012 | - | $16.32 M(+9.1%) | $53.02 M(+15.5%) |
| Dec 2011 | $45.92 M(+69.0%) | $14.96 M(+36.9%) | $45.92 M(+17.0%) |
| Sep 2011 | - | $10.93 M(+1.1%) | $39.26 M(+12.8%) |
| Jun 2011 | - | $10.80 M(+17.1%) | $34.81 M(+13.7%) |
| Mar 2011 | - | $9.22 M(+11.1%) | $30.61 M(+12.7%) |
| Dec 2010 | $27.17 M(+42.7%) | $8.30 M(+28.1%) | $27.17 M(+11.1%) |
| Sep 2010 | - | $6.48 M(-1.8%) | $24.46 M(+6.7%) |
| Jun 2010 | - | $6.60 M(+14.1%) | $22.92 M(+3.7%) |
| Mar 2010 | - | $5.79 M(+3.5%) | $22.11 M(+2.7%) |
| Dec 2009 | $19.04 M(+3.9%) | $5.59 M(+13.1%) | $21.51 M(+35.1%) |
| Sep 2009 | - | $4.94 M(-14.7%) | $15.93 M(+45.0%) |
| Jun 2009 | - | $5.79 M(+11.5%) | $10.98 M(+111.5%) |
| Mar 2009 | - | $5.19 M | $5.19 M |
| Dec 2008 | $18.33 M(+69.2%) | - | - |
| Dec 2007 | $10.83 M | - | - |
FAQ
- What is Ironwood Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual SGA year-on-year change?
- What is Ironwood Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly SGA year-on-year change?
- What is Ironwood Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals TTM SGA year-on-year change?
What is Ironwood Pharmaceuticals annual SGA?
The current annual SGA of IRWD is $158.31 M
What is the all time high annual SGA for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual SGA is $231.18 M
What is Ironwood Pharmaceuticals annual SGA year-on-year change?
Over the past year, IRWD annual SGA has changed by +$42.32 M (+36.48%)
What is Ironwood Pharmaceuticals quarterly SGA?
The current quarterly SGA of IRWD is $36.11 M
What is the all time high quarterly SGA for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly SGA is $61.77 M
What is Ironwood Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, IRWD quarterly SGA has changed by $0.00 (0.00%)
What is Ironwood Pharmaceuticals TTM SGA?
The current TTM SGA of IRWD is -$6.81 B
What is the all time high TTM SGA for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high TTM SGA is -$243.37 M
What is Ironwood Pharmaceuticals TTM SGA year-on-year change?
Over the past year, IRWD TTM SGA has changed by -$6.95 B (-4656.46%)